Fauna Bio
@faunabio
Developing new therapies inspired by disease resistance in animals
Excited to announce the launch of Fauna Brain™, a proprietary AI platform designed to accelerate target discovery and streamline early-stage R&D. The platform represents a major evolution of Fauna Bio’s Convergence™ discovery engine. 🧬🧬 businesswire.com/news/home/2025…
Our CEO @ashleyz413 will be speaking at @SynBioBeta on May 7 at 4.30 pm. More info here: synbiobeta.com
Congrats to our co-founders @ashleyz413 @krgrabek and @LindaBGoodman for being named to this year’s @Inc Female Founders 500 list! 🌟 See the full list: events.inc.com/female-founder…
Our CEO @ashleyz413 will be at #InvestivalShowcase in Miami, March 10-11. @LSXLeaders More info here: informaconnect.com/investival-sho…
Our CEO & Co-Founder @ashleyz413 on the SIC Ventures and @StanfordMed event at #JPM25. Great discussion with female execs discussing raising funding for their biotech. 🧬🧬
Our CEO & Co-Founder @ashleyz413 will be speaking at the @StanfordMed SIC Venture Studio next Tuesday Jan 14, 11.30 am PT during #JPM25 Healthcare Conference. 🧬🧬 Register to attend: 👇👇 lu.ma/x7iuffoo
It’s been so exciting to see the data coming out of this program!
We’re excited to select Faun1083 as our first development candidate. Discovered through our proprietary Convergence™ drug discovery platform, Faun1083 is a potential first-in-class therapeutic targeting heart failure with preserved ejection fraction. 🧬 businesswire.com/news/home/2025…
We’re excited to select Faun1083 as our first development candidate. Discovered through our proprietary Convergence™ drug discovery platform, Faun1083 is a potential first-in-class therapeutic targeting heart failure with preserved ejection fraction. 🧬 businesswire.com/news/home/2025…
📣 Speaker Announcement! We’re excited to announce that Ashley Zehnder, Co-Founder & CEO at Fauna Bio will be speaking at Biotech Showcase 2025! Find out more about what is in store at Biotech Showcase >> spr.ly/6010Qj5vq #BiotechShowcase #Biotech #Financing
Our CEO @ashleyz413 spoke with @cenmag reporter @rowanwalrath about founder-led #biotechs 🔥🔥🔥 cen.acs.org/business/start…
Ashley Zehnder @faunabio discusses the insights that can be gleaned from the genetics of hibernating animals, the human health conditions that might be addressed with the approach, and the company’s deal with Eli Lilly to discover new obesity drugs. thebioreport.podbean.com/e/going-to-ext…
Our CEO @ashleyz413 will be speaking at the #BIO Investor Forum today at 1 pm PT. Check out the agenda: bif.bio.org/event-overview
.@neiltyson, Chuck Nice, and Gary O’Reilly team up with Ryan Sprenger, Senior Research Scientist at Fauna Bio, to explore a question straight out of science fiction: can humans #hibernate in space like animals do on Earth? @StarTalkRadio 🌎🪐 Watch here: youtu.be/Ph5cr3KSCUg?si…
Our CEO @ashleyz413 will be speaking at @LSXLeaders in Boston today at 11 am ET. Hope to see you all there! Sharing more info: informaconnect.com/lsx-world-cong…
Excited to be speaking alongside @ashleyz413 September 26th- Women in Bio (WIB) panel- Transforming Drug Discovery- How AI/ML and Women Leaders are Changing the Game. Register: community.womeninbio.org/event/sanfran9…
The @NASA NIAC symposium is free to live stream. Current projects from proof of concept to launch are being presented and discussed! Be sure to check out our @faunabio project presented by Dr. Sprenger on Sept. 11th at 11:30 Pacific time. vimeo.com/showcase/10973…
We’re humbled for our work to be featured in @NatureMedicine. Thanks for speaking with our CEO @ashleyz413 and we’re excited to keep everyone updated on our progress! More soon. #hiberation #biology #obesity nature.com/articles/s4159…
